EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prospective on Imaging Mass Spectrometry in Clinical Diagnostics

Jessica L Moore, Nathan Heath Patterson, Jeremy L Norris, Richard M Caprioli

Molecular & Cellular Proteomics · 2023-09 · 22 (9) · 100576

DOI: 10.1016/j.mcpro.2023.100576 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular & Cellular Proteomics, 2023-09. Verfasst von Jessica L Moore und 3 weiteren Autor:innen. Beteiligte Einrichtung: Frontier Diagnostics, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Reproducibility of Results. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, VANDERBILT UNIVERSITY, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Imaging mass spectrometry (IMS) is a molecular technology utilized for spatially driven research, providing molecular maps from tissue sections. This article reviews matrix-assisted laser desorption ionization (MALDI) IMS and its progress as a primary tool in the clinical laboratory. MALDI mass spectrometry has been used to classify bacteria and perform other bulk analyses for plate-based assays for many years. However, the clinical application of spatial data within a tissue biopsy for diagnoses and prognoses is still an emerging opportunity in molecular diagnostics. This work considers spatially driven mass spectrometry approaches for clinical diagnostics and addresses aspects of new imaging-based assays that include analyte selection, quality control/assurance metrics, data reproducibility, data classification, and data scoring. It is necessary to implement these tasks for the rigorous translation of IMS to the clinical laboratory; however, this requires detailed standardized protocols for introducing IMS into the clinical laboratory to deliver reliable and reproducible results that inform and guide patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reproducibility of ResultsHumansSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Stichwörter der Autor:innen

MALDI MSclinical diagnosticsclinical proteomicsimagingimaging mass spectrometry

Autor:innen und Institutionen

  • Frontier Diagnostics, Nashville, Tennessee, USA.
  • Frontier Diagnostics, Nashville, Tennessee, USA; Vanderbilt University Mass Spectrometry Research Center, Vanderbilt University, Nashville, Tennessee, USA.
  • Frontier Diagnostics, Nashville, Tennessee, USA; Vanderbilt University Mass Spectrometry Research Center, Vanderbilt University, Nashville, Tennessee, USA; Departments of Biochemistry, Pharmacology, Chemistry, and Medic…

Förderung

  • NIDDK NIH HHS
  • VANDERBILT UNIVERSITY
  • National Institutes of Health

Zitieren

APA

Moore, J. L., Patterson, N. H., Norris, J. L., & Caprioli, R. M. (2023). Prospective on Imaging Mass Spectrometry in Clinical Diagnostics. Molecular & Cellular Proteomics, 22(9), 100576. https://doi.org/10.1016/j.mcpro.2023.100576

Vancouver

Moore JL, Patterson NH, Norris JL, Caprioli RM. Prospective on Imaging Mass Spectrometry in Clinical Diagnostics. Molecular & Cellular Proteomics. 2023;22(9):100576. doi:10.1016/j.mcpro.2023.100576

BibTeX
@article{Moore2023,
  author = {Moore, Jessica L and Patterson, Nathan Heath and Norris, Jeremy L and Caprioli, Richard M},
  title = {Prospective on Imaging Mass Spectrometry in Clinical Diagnostics},
  journal = {Molecular & Cellular Proteomics},
  year = {2023},
  volume = {22},
  number = {9},
  pages = {100576},
  doi = {10.1016/j.mcpro.2023.100576}
}
Kostenlos starten →